The Co-Localization of NLRP3 and ASC Specks Does Not Automatically Entail NLRP3 Inflammasome Functionality in PDAC Cell Lines
Journal article, 2024

The NLRP3 inflammasome is an important mediator of the host inflammatory response, and downregulation of inflammation is important in cancer treatment. Here, we investigated four different pancreatic ductal adenocarcinoma (PDAC) cell lines, AsPC-1, BxPC-3, CFPAC-1 and Panc-1, with regards to NLRP3 inflammasome formation and cytokine secretion. ASC specks were observed in all the cell lines investigated, but AsPC-1 was the only cell-line with the co-localization of anti-ASC and anti-NLRP3 and spontaneously formed multiple NLRP3 inflammasomes per cell. The co-localization of NLRP3 and ASC was not accompanied by IL-1β release nor significant IL-18 release. BxPC-3 displayed relatively high expression of the inflammasome-related genes IL1B and CASP1 and had the highest levels of IL1β and IL18 secretion and the highest amount of ASC. The inflammasome-associated genes IL18 and PYCARD were up-regulated in the PDAC primary tumors compared to normal tissue, and high PDAC tumor expression of IL18, CASP1 and PYCARD correlated with low patient survival. We have shown that PDAC cell lines display significant variations in their inflammasome-related gene expression and readouts. We conclude that spontaneous ASC speck formation is possible in PDAC cells and that multiple NLRP3 inflammasomes are formed spontaneously in AsPC-1 cells but that the co-localization of NLRP3 and ASC specks does not automatically entail inflammasome function.

NLRP3

pancreatic ductal adenocarcinoma (PDAC)

cancer

ASC

inflammasome

PYCARD

Author

Heléne Lindholm

University of Skövde

Faculty of Medicine and Health

Matthew Herring

University of Skövde

Faculty of Medicine and Health

Örebro University

Maria Faresjö

Chalmers, Life Sciences

Johan Haux

Skaraborg Hospital

University of Skövde

Ferenc Szekeres

University of Skövde

K. Ejeskar

University of Skövde

International Journal of Translational Medicine

26738937 (eISSN)

Vol. 4 2 224-237

Subject Categories (SSIF 2025)

Cell and Molecular Biology

DOI

10.3390/ijtm4020013

More information

Latest update

2/21/2025